Arca
Skip to content

Prostate adenocarcinoma

Drug research and approvals for prostate adenocarcinoma: what is recruiting, what Health Canada authorized, FDA orphan designations and EU medicines. See every condition.

As of Nov 16, 2026, 182 studies of prostate adenocarcinoma are recruiting on ClinicalTrials.gov, and Health Canada has authorized 6 drug trials for it since 2013.

  • Recruiting worldwide: 182
  • Trials authorized in Canada: 6
  • FDA orphan approvals: 0
  • EU medicines: 0

Recruiting Now

Newest start dates first, of 182 recruiting on ClinicalTrials.gov ↗

Trials Authorized in Canada

Newest first; search them all in Canada trials
Mar 26, 2024Phase III study of hypofractionated, dose escalation radiotherapy and brachytherapy for intermediate risk adenocarcinoma of the prostate with 6 versus 12…LEUPROLIDEHOPITAL CHARLES LEMOYNEPending
Feb 28, 2022A phase III double-blind, randomised, placebo-controlled study assessing the efficacy and safety of capivasertib + docetaxel versus placebo + docetaxel as…CAPIVASERTIB (AZD5363)/ DOCETAXELAstraZeneca Pharmaceuticals LPClosed
May 16, 2018Prevention of metabolic syndrome and increased weight using metformin concurrent to androgen deprivation therapy and radiotherapy for locally advanced…METFORMINPRAIRIE MOUNTAIN HEALTHOngoing
Jun 17, 2015Barrier-p trial: biomarkers of androgen response and resistance in evolution during a rising psaATORVASTATIN/ METFORMINUNIVERSITY HEALTH NETWORKOngoing
Oct 23, 2014Phase III study of hypofractionated, dose escalation radiotherapy vs. standard pelvic radiation therapy followed by hdr brachy boost for high risk…LEUPROLIDE/ BICALUTAMIDEJEWISH GENERAL HOSPITALOngoing
Jul 2, 2014Premium - prevention of metabolic syndrome and increased weight using metformin concurrent to androgen deprivation therapy and radiotherapy for high risk,…METFORMINALBERTA HEALTH SERVICESClosed

Condition names come from Health Canada's trial database. Orphan designations and EU medicines are matched when their indication names the condition as whole words, so a broader or differently worded indication can be missed. Recruiting counts are live from ClinicalTrials.gov's own condition search, refreshed daily. ClinicalTrials.gov, Health Canada Clinical Trials Database, FDA orphan designations, EMA

Logos are each company's own site icon, matched by name through Wikidata.Company names and logos identify the companies in public FDA and registry records and do not imply endorsement.